December 12, 2023Journal of the American Heart Association40 citationsOpen Access

Impact of Sodium‐Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With Diabetes: A Propensity‐Score Matching Study and Meta‐Analysis

ZZZixu Zhao CJChao Jiang LHLiu He

Structured PICO

Does SGLT2i reduce AF recurrence in patients with diabetes after AF ablation?

Population

Patients with diabetes undergoing catheter ablation for atrial fibrillation

Intervention

Sodium-glucose cotransporter 2 inhibitors (SGLT2i)

Outcome

Atrial fibrillation (AF) recurrencehard clinical

SGLT2 inhibitors may reduce the risk of atrial fibrillation recurrence following catheter ablation in patients with diabetes.

Abstract

Our prospective study coupled with a meta-analysis demonstrated a lower risk of AF recurrence with the use of SGLT2i among patients with diabetes after AF ablation.

问 AI

Bookmark

View Full Paper